| Investor Type | Firm |
| Type of Fund | Venture Capital Fund |
| Industries | Cosmetics (& Fashion) • IoT (& Wearables) • A.I. (& Big Data) • HealthTech (& Fitness) • Analytics • Healthcare (& Wellness) • Life Science • Pharmaceutical (& Medicine) |
| Stages | Pre-seed, Seed |
| Investing | United States • United Kingdom • India • Japan • France • Mexico • Sweden • Switzerland • Netherlands • Denmark • Singapore • Austria • Finland • Norway |
| Investment Range | $250,000 - $10,000,000 |
DigitalDx Ventures is a specialized venture capital firm that has set its focus on fostering game-changing innovation at the intersection of Artificial Intelligence and Healthcare. Located in Menlo Park, California, DigitalDx adopts a forward-looking investment approach, channeling capital into the life sciences sector with a specific emphasis on startups leveraging AI to transform healthcare. The firm is built on a foundation of an experienced team, comprised of Michele Colucci, Eric Weiss, Anula Jayasuriya, and others, who bring together a diverse set of skills and backgrounds to support portfolio companies.
They also have a range of Entrepreneurs in Residence (EIRs) and Advisors, including Jerry Lanchbury, Debbie Lin, and noted industry experts such as Deborah DiSanzo and Russ Altman, contributing wisdom and expertise to guide the ambitious path of their investments. Moreover, DigitalDx Ventures shows a commitment to fostering diversity, equity, and inclusion within its operations and investments, evidenced by initiatives targeted at achieving gender parity and broader ESG goals. They showcase a comprehensive portfolio of companies that reflect their market segmentation strategy and focus on a significant market opportunity.
As a firm, they express a keen interest in shaping the future of healthcare by enabling innovative solutions that may not only make significant strides in the field but also potentially deliver on a promise of better patient outcomes and more efficient healthcare systems.
We are a women owned and run seed stage VC fund. We have 25 scientific and AI experts and 225 alumni fellows (MD, PhD, MS, MBA) on our team who source, diligence and counsel our companies. We incubate ideas and fund founders coming out of leading labs around the world.
What we look for: We invest in AI and healthcare with a focus on early detection and personalized medicine in large scale diseases like cancer, Alzheimer's and infectious diseases. Our thesis is that the human body is a Big Data problem that AI can now solve.
How we help: We see deals before others. We are leaders in the diagnostic space for the last eight years and have great relationships with large companies who join our cap tables.
